UNSPSC 51112528: Spiromustine

This classification denotes a nitrogen mustard compound with the molecular formula C14H23Cl2N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J3HB83X76Z, chemically known as 1,3-diazaspiro(4.5)decane-2,4-dione, 3-(2-(bis(2-chloroethyl)amino)ethyl)- but more generally known as spiromustine, which bears US NIH Compound Identifier 41945. European Medicines Agency schedules Spiromustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10630MIG.

UNSPSC 51112528 Spiromustine is a Commodity code covering procurement of the chemotherapy agent spiromustine, a nitrogen mustard derivative used in oncology treatment. State and local governments procure this drug through their healthcare systems, primarily for cancer care delivery at hospital oncology departments and specialized treatment centers. The code reflects purchases of spiromustine as a finished pharmaceutical product, typically acquired through established pharmaceutical supply chains and distributed inventory management systems within state health agencies or large municipal hospital networks.

The source provides no recent state or local solicitation activity under this code. Without posted opportunities or active bidding cycles, this code shows no current purchasing momentum at the state and local level to evaluate at this time.